Comparative in vitro and in vivo assessment of toxin neutralization by anti-tetanus toxin monoclonal antibodies

References

• Lacy DB, Tepp W, Cohen AC, DasGupta BR, Stevens RC. Crystal structure of botulinum neurotoxin type A and implications for toxicity. Nat StructBiol 1998; 5:898 - 902; http://dx.doi.org/10.1038/2338; PMID: 9783750
   PubMedGoogle Scholar
• Swaminathan S, Eswaramoorthy S. Structural analysis of the catalytic and binding sites of Clostridium botulinum neurotoxin B. Nat StructBiol 2000; 7:693 - 9; http://dx.doi.org/10.1038/78005; PMID: 10932256
   PubMedGoogle Scholar
• Schiavo G, Matteoli M, Montecucco C. Neurotoxins affecting neuroexocytosis. Physiol Rev 2000; 80:717 - 66; PMID: 10747206
   PubMed Web of Science ®Google Scholar
• Montecucco C, Schiavo G. Structure and function of tetanus and botulinum neurotoxins. Q Rev Biophys 1995; 28:423 - 72; http://dx.doi.org/10.1017/S0033583500003292; PMID: 8771234
   PubMed Web of Science ®Google Scholar
• Herreros J, Ng T, Schiavo G. Lipid rafts act as specialized domains for tetanus toxin binding and internalization into neurons. MolBiol Cell 2001; 12:2947 - 60; http://dx.doi.org/10.1091/mbc.12.10.2947; PMID: 11598183
   PubMed Web of Science ®Google Scholar
• Herreros J, Lalli G, Schiavo G. C-terminal half of tetanus toxin fragment C is sufficient for neuronal binding and interaction with a putative protein receptor. Biochem J 2000; 347:199 - 204; http://dx.doi.org/10.1042/0264-6021:3470199; PMID: 10727419
   PubMed Web of Science ®Google Scholar
• Montecucco C, Rossetto O, Schiavo G. Presynaptic receptor arrays for clostridial neurotoxins. Trends Microbiol 2004; 12:442 - 6; http://dx.doi.org/10.1016/j.tim.2004.08.002; PMID: 15381192
   PubMed Web of Science ®Google Scholar
• Swaminathan S. Molecular structures and functional relationships in clostridial neurotoxins. FEBS J 2011; 278:4467 - 85; http://dx.doi.org/10.1111/j.1742-4658.2011.08183.x; PMID: 21592305
   PubMed Web of Science ®Google Scholar
• Gustafsson B, Whitmore E, Tiru M. Neutralization of tetanus toxin by human monoclonal antibodies directed against tetanus toxin fragment C. Hybridoma 1993; 12:699 - 708; http://dx.doi.org/10.1089/hyb.1993.12.699; PMID: 8288271
   PubMed Web of Science ®Google Scholar
• Fitzsimmons SP, Clark KC, Wilkerson R, Shapiro MA. Inhibition of tetanus toxin fragment C binding to gangliosideG(T1b) by monoclonal antibodies recognizing different epitopes. Vaccine 2000; 19:114 - 21; http://dx.doi.org/10.1016/S0264-410X(00)00115-8; PMID: 10924793
   PubMed Web of Science ®Google Scholar
• Schengrund CL, DasGupta BR, Ringler NJ. Binding of botulinum and tetanus neurotoxins to ganglioside GT1b and derivatives thereof. J Neurochem 1991; 57:1024 - 32; http://dx.doi.org/10.1111/j.1471-4159.1991.tb08253.x; PMID: 1861141
   PubMed Web of Science ®Google Scholar
• Yousefi M, Tahmasebi F, Younesi V, Razavi A, Khoshnoodi J, Bayat AA, Abbasi E, Rabbani H, Jeddi-Tehrani M, Shokri F. Characterization of neutralizing monoclonal antibodies directed against tetanus toxin fragment C. J Immunotoxicol 2013; Forthcoming http://dx.doi.org/10.3109/1547691X.2013.763872; PMID: 23369087
   PubMed Web of Science ®Google Scholar
• Diethelm-Okita BM, Okita DK, Banaszak L, Conti-Fine BM. Universal epitopes for human CD4+ cells on tetanus and diphtheria toxins. J Infect Dis 2000; 181:1001 - 9; http://dx.doi.org/10.1086/315324; PMID: 10720523
   PubMed Web of Science ®Google Scholar
• Tymciu S, Durieux-Alexandrenne C, Wijkhuisen A, Créminon C, Frobert Y, Grassi J, Couraud JY, Boquet D. Enhancement of antibody responses in DNA vaccination using a vector encoding a universal T-helper cell epitope. DNA Cell Biol 2004; 23:395 - 402; http://dx.doi.org/10.1089/104454904323145281; PMID: 15231073
   PubMed Web of Science ®Google Scholar
• Holmgren J, Elwing H, Fredman P, Svennerholm L. Polystyrene-adsorbed gangliosides for investigation of the structure of the tetanus-toxin receptor. Eur J Biochem 1980; 106:371 - 9; http://dx.doi.org/10.1111/j.1432-1033.1980.tb04583.x; PMID: 7398619
   PubMedGoogle Scholar
• Emsley P, Fotinou C, Black I, Fairweather NF, Charles IG, Watts C, Hewitt E, Isaacs NW. The structures of the H(C) fragment of tetanus toxin with carbohydrate subunit complexes provide insight into ganglioside binding. J BiolChem 2000; 275:8889 - 94; http://dx.doi.org/10.1074/jbc.275.12.8889; PMID: 10722735
   PubMed Web of Science ®Google Scholar
• Fotinou C, Emsley P, Black I, Ando H, Ishida H, Kiso M, Sinha KA, Fairweather NF, Isaacs NW. The crystal structure of tetanus toxin Hc fragment complexed with a synthetic GT1b analogue suggests cross-linking between ganglioside receptors and the toxin. J BiolChem 2001; 276:32274 - 81; http://dx.doi.org/10.1074/jbc.M103285200; PMID: 11418600
   PubMed Web of Science ®Google Scholar
• Rummel A, Bade S, Alves J, Bigalke H, Binz T. Two carbohydrate binding sites in the H(CC)-domain of tetanus neurotoxin are required for toxicity. J MolBiol 2003; 326:835 - 47; http://dx.doi.org/10.1016/S0022-2836(02)01403-1; PMID: 12581644
   PubMed Web of Science ®Google Scholar
• Herreros J, Lalli G, Montecucco C, Schiavo G. Tetanus toxin fragment C binds to a protein present in neuronal cell lines and motoneurons. J Neurochem 2000; 74:1941 - 50; http://dx.doi.org/10.1046/j.1471-4159.2000.0741941.x; PMID: 10800937
   PubMed Web of Science ®Google Scholar
• Slade AL, Schoeniger JS, Sasaki DY, Yip CM. In situ scanning probe microscopy studies of tetanus toxin-membrane interactions. Biophys J 2006; 91:4565 - 74; http://dx.doi.org/10.1529/biophysj.105.080457; PMID: 16997879
   PubMed Web of Science ®Google Scholar
• Gigliotti F, Insel RA. Protective human hybridoma antibody to tetanus toxin. J Clin Invest 1982; 70:1306 - 9; http://dx.doi.org/10.1172/JCI110730; PMID: 7174795
   PubMed Web of Science ®Google Scholar
• Trabaud MA, Lery L, Desgranges C. Human monoclonal antibodies with a protective activity against tetanus toxin. APMIS 1989; 97:671 - 6; http://dx.doi.org/10.1111/j.1699-0463.1989.tb00461.x; PMID: 2475149
   PubMed Web of Science ®Google Scholar
• Kamei M, Hashizume S, Sugimoto N, Ozutsumi K, Matsuda M. Establishment of stable mouse/human-human hybrid cell lines producing large amounts of anti-tetanus human monoclonal antibodies with high neutralizing activity. Eur J Epidemiol 1990; 6:386 - 97; http://dx.doi.org/10.1007/BF00151713; PMID: 2091939
   PubMed Web of Science ®Google Scholar
• Arunachalam B, Ghosh S, Talwar GP, Raghupathy R. A single human monoclonal antibody that confers total protection from tetanus. Hybridoma 1992; 11:165 - 79; http://dx.doi.org/10.1089/hyb.1992.11.165; PMID: 1376715
   PubMed Web of Science ®Google Scholar
• Ahnert-Hilger G, Bizzini B, Goretzki K, Müller H, Völckers C, Habermann E. Monoclonal antibodies against tetanus toxin and toxoid. Med MicrobiolImmunol 1983; 172:123 - 35; http://dx.doi.org/10.1007/BF02124513; PMID: 6193402
   PubMed Web of Science ®Google Scholar
• GreenspanNS, CooperLJ. Cooperative binding by mouse IgG3 antibodies: implications for functional affinity, effector function, and isotype restriction. Springer seminars in immunopathology: Springer, 1993:275-91.
   Google Scholar
• Greenspan NS. Affinity, complementarity, cooperativity, and specificity in antibody recognition. Curr Top MicrobiolImmunol 2001; 260:65 - 85; http://dx.doi.org/10.1007/978-3-662-05783-4_5; PMID: 11443882
   PubMed Web of Science ®Google Scholar
• Scott N, Qazi O, Wright MJ, Fairweather NF, Deonarain MP. Characterisation of a panel of anti-tetanus toxin single-chain Fvs reveals cooperative binding. MolImmunol 2010; 47:1931 - 41; http://dx.doi.org/10.1016/j.molimm.2010.02.020; PMID: 20413159
   PubMed Web of Science ®Google Scholar